New possibilities for leukemia therapy with a novel mode of leukemia cell recognition

A new class of lipids in human leukemia cells trigger an immune response to kill the cells

2014-06-24

(Press-News.org) Singapore, 24 June 2014—Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered a new class of lipids in the leukaemia cells that are detected by a unique group of immune cells. By recognising the lipids, the immune cells stimulate an immune response to destroy the leukaemia cells and suppress their growth. The newly identified mode of cancer cell recognition by the immune system opens up new possibilities for leukaemia immunotherapy .

Leukaemia is characterized by the accumulation of cancer cells originating from blood cells, in the blood or bone marrow. Current treatments for leukaemia largely involve chemotherapy to eradicate all cancer cells, followed by stem cell transplants to restore healthy blood cells in the patients.

In a recent study reported in the Journal of Experimental Medicine (JEM) online, the team co-led by Dr Lucia Mori and Prof Gennaro De Libero identified a new class of lipids, methyl-lysophosphatidic acids (mLPA), which accumulate in leukaemia cells. Following which, the team identified a specific group of immune cells, described as mLPA-specific T-cells that are capable of recognising the mLPA in the leukaemia cells. The detection triggers an immune response that activates the T cells to kill the leukaemia cells and limits cancer progression. The efficacy of the T cells in killing leukaemia cells was also demonstrated in a mouse model of human leukaemia.

Thus far, only proteins in cancer cells have been known to activate T cells. This study is a pioneer in its discovery of mLPA, and the specific T cells which can identify lipids expressed by cancer cells. Unlike proteins, lipids in cancer cells do not differ between individuals, indicating that the recognition of mLPA by mLPA-specific T-cells happens in all leukaemia patients. This new mode of cancer cell recognition suggests that the T-cells can potentially be harnessed for a leukaemia immunotherapy that is effective in all patients.

"The identification of mLPA and its role in activating specific T cells is novel. This knowledge not only sheds light on future leukaemia studies, but also complements ongoing leukaemia immunotherapy studies focusing on proteins in cancer cells," said Dr Lucia Mori, Principal Investigator at SIgN. "Current treatments run the risk of failure due to re-growth of residual leukaemia cells that survive after stem cell transplants. T-cell immunotherapy may serve as a complementary treatment for more effective and safer therapeutic approach towards leukaemia."

Professor Laurent Renia, Acting Executive Director of SIgN, said, "At SIgN, we study how the human immune system protects us naturally from infections. We engage in promising disease-specific research projects that ultimately pave the way for the development of treatments and drugs which can better combat these diseases. A pertinent example will be this study; this mode of immune recognition of leukaemia cells is an insightful discovery that will create new opportunities for immunotherapy to improve the lives of leukaemia patients."

INFORMATION: Notes to Editor:

The research findings described in this media release can be found in the Journal of Experimental Medicine, under the title, "A novel self-lipid antigen targets human T cells against CD1c+ leukaemias" by Marco Lepore1,2,11, Claudia de Lalla2,11, Gundimeda S. Ramanjaneyulu1,11, Heiko Gsellinger3, Michela Consonni2,Claudio Garavaglia2, Sebastiano Sansano1, Francesco Piccolo2 Andrea Scelfo2, Daniel Häussinger3, Daniela Montagna4 ,Franco Locatelli5, Chiara Bonini6, Attilio Bondanza6, Alessandra Forcina7, Zhiyuan Li8, Guanghui Ni,8 Fabio Ciceri7, Paul Jenö9, Chengfeng Xia8, Lucia Mori1,10 , Paolo Dellabona2, Giulia Casorati2 and Gennaro De Libero1,10

1Experimental Immunology, Department of Biomedicine, University Hospital Basel, 4031 Basel, Switzerland
2Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, 20132 Milano, Italy
3NMR-Laboratory, Department of Chemistry, University of Basel, 4056 Basel, Switzerland
4Laboratory of Immunology, Department of Pediatrics, University of Pavia and Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
5Department of Pediatric Hematology-Oncology, IRCCS Bambino Gesù Hospital, 00165 Rome, Italy
6Experimental Hematology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy
7Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, 20132 Milan, Italy
8State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, China
9Department of Biochemistry, Biozentrum, University of Basel, 4056 Basel, Switzerland,
10Singapore Immunology Network (SIgN), Agency for Science, Technology and Research, 138648 Singapore
11M.L., C.d.L. and G.S.R. contributed equally to this work

Full text of the Journal of Experimental Medicine paper can be accessed online from: http://jem.rupress.org/content/early/2014/06/11/jem.20140410.abstract For media queries and clarifications, please contact:

Tan Yun Yun
Senior Officer, Corporate Communications
Agency for Science, Technology and Research
Tel: +65 6826 6273
Email: tan_yun_yun@a-star.edu.sg About the Singapore Immunology Network (SIgN)

The Singapore Immunology Network (SIgN), officially inaugurated on 15 January 2008, is a research consortium under the Agency for Science, Technology and Research (A*STAR)'s Biomedical Research Council. The mandate of SIgN is to advance human immunology research and participate in international efforts to combat major health problems. Since its launch, SIgN has grown rapidly and currently includes 250 scientists from 26 different countries around the world working under 28 renowned principal investigators. At SIgN, researchers investigate immunity during infection and various inflammatory conditions including cancer and are supported by cutting edge technological research platforms and core services.

Through this, SIgN aims to build a strong platform in basic human immunology research for better translation of research findings into clinical applications. SIgN also sets out to establish productive links with local and international institutions, and encourage the exchange of ideas and expertise between academic, industrial and clinical partners and thus contribute to a vibrant research environment in Singapore.

For more information about SIgN, please visit http://www.sign.a-star.edu.sg.

About the Agency for Science, Technology and Research (A*STAR)

The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector agency that fosters world-class scientific research and talent to drive economic growth and transform Singapore into a vibrant knowledge-based and innovation driven economy.

In line with its mission-oriented mandate, A*STAR spearheads research and development in fields that are essential to growing Singapore's manufacturing sector and catalysing new growth industries. A*STAR supports these economic clusters by providing intellectual, human and industrial capital to its partners in industry.

A*STAR oversees 18 biomedical sciences and physical sciences and engineering research entities, located in Biopolis and Fusionopolis, as well as their vicinity. These two R&D hubs house a bustling and diverse community of local and international research scientists and engineers from A*STAR's research entities as well as a growing number of corporate laboratories.

For more information on A*STAR, please visit http://www.a-star.edu.sg.

ELSE PRESS RELEASES FROM THIS DATE:

NTU study shows puzzle games can improve mental flexibility

2014-06-24

Want to improve your mental finesse? Playing a puzzle game like Cut the Rope could just be the thing you need. A recent study by Nanyang Technological University (NTU) scientists showed that adults who played the physics-based puzzle video game Cut the Rope regularly, for as little as an hour a day, had improved executive functions. The executive functions in your brain are important for making decisions in everyday life when you have to deal with sudden changes in your environment – better known as thinking on your feet. An example would be when the traffic light ...

Cancer: The roots of evil go deep in time

2014-06-24

Every year around 450,000 people in Germany are diagnosed with cancer. Each one of them dreams of a victory in the battle against it. But can cancer ever be completely defeated? Researchers at Kiel University (CAU) have now reached a sobering conclusion: "cancer is as old as multi-cellular life on earth and will probably never be completely eradicated", says Professor Thomas Bosch in his latest research results. The study by an international team led by Bosch was published today (Monday, June 24) in the prestigious scientific journal Nature Communications. The so-called ...

The great salmon run algorithm

2014-06-24

Solving complex problems is rarely a straightforward process, there are often many variables and countless plausible solutions each one of which has its pros and cons. Mechanical engineers at the Babol University of Technology in Mazandaran, Iran, have turned to nature to devise an algorithm based on the survival trials faced by salmon swimming upstream to the spawning grounds to help them fish out the optimal solution to a given problem. They provide details in the International Journal of Computer Applications in Technology. Bio-inspiration has been widely used in problem ...

Restricting competitors could help threatened species cope with climate change

2014-06-24

Threatened animal species could cope better with the effects of climate change if competition from other animals for the same habitats is restricted, according to new research by Durham University. The Durham team studied the impacts of climate on the Alpine Chamois, a species of mountain goat, and the effects that domestic sheep had on the goats' movements. Observing the goats in the Italian Alps during the summer, the researchers found that Chamois tended to move to higher altitudes where it is cooler on hotter days and in the middle of the day, but moved much higher ...

The National Health Service -- committed to failure?

2014-06-24

London (24 June 2014). A project has failed. So why continue to invest in it? This is a pertinent question for large organisations, like the UK National Health Service, which has a history of investing vast amounts of taxpayer's money into unrealistic and ultimately unsuccessful projects. According to business experts, organisations develop blind spots due to a perfect storm of unworkable policies and defensive behaviour. In fact, organisations and individuals have a few things in common, psychologically speaking, when it comes to throwing good money after bad, the experts ...

Dental hygiene profession sees moment of opportunity to improve access to oral health care

2014-06-24

St. Louis, June 23, 2014 – With opportunities to take increased responsibility for oral health care and to deliver care in a more comprehensive way, it's an exciting time in the profession of dental hygiene. To help prepare to meet these challenges, the editors of The Journal of Evidence-Based Dental Practice (JEBDP) present the Annual Report on Dental Hygiene, a collection of cutting-edge research and practice updates in the field of dental hygiene. The JEBDP is the foremost publication of information about evidence-based dental practice and is published by Elsevier, ...

Cell division discovery could optimise timing of chemotherapy and explain some cancers

2014-06-24

Research led by the University of Warwick's Systems Biology Centre and Medical School in collaboration with groups in Nice and Rotterdam has been able to demonstrate how the cycle of cell division in mammalian cells synchronises with the body's own daily rhythm, its circadian clock. The study not only helps to explain why people with sustained disrupted circadian rhythms can be more susceptible to cancer, it may also help establish the optimal time of day to administer chemotherapy. In a paper entitled Phase locking and multiple oscillating attractors for the coupled ...

Growing unknown microbes 1 by 1

2014-06-24

Trillions of bacteria live in and on the human body; a few species can make us sick, but many others keep us healthy by boosting digestion and preventing inflammation. Although there's plenty of evidence that these microbes play a collective role in human health, we still know very little about most of the individual bacterial species that make up these communities. Employing the use of a specially designed glass chip with tiny compartments, Caltech researchers now provide a way to target and grow specific microbes from the human gut—a key step in understanding which bacteria ...

Montana State University professor and brain scientist continues exploring the brain

2014-06-24

BOZEMAN, Mont. A Montana State University assistant professor in neuroscience is part of a team that has made progress understanding how the brain processes visual information. In addition to adding to the basic understanding of brain function, the research may also have implications for understanding schizophrenia and attention deficit disorders. MSU's Behrad Noudoost was a co-author with Marc Zirnsak and other neuroscientists from the Tirin Moore Lab at Stanford University in publishing a recent paper on the research in Nature, an international weekly journal for natural ...

CU Denver study shows more bicyclists on road means fewer collisions

2014-06-24

DENVER (June 24, 2014) - A University of Colorado Denver study examining collisions between bicycles and motorists, shows bicyclist safety significantly increases when there are more bikes on the road, a finding that could be attributed to a "safety in numbers effect." The study focused on Boulder, Colorado, which has one of the highest rates of bicycling in the country at about 12 percent of the population. That makes it one of the few U.S. cities with enough bicycling to achieve the safety benefits already documented by researchers in Europe, said study co-author ...

Tufts University School of Medicine, ATI Physical Therapy launch first-of-its-kind collaboration to make physical therapy education and career advancement more accessible and affordable

New possibilities for leukemia therapy with a novel mode of leukemia cell recognition

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: